Kijimea® is a dietary supplement containing the unique bifidobacterial strain B. bifidum MIMBb75.

Kijimea® at a glance:

Contains the unique bacterial strain B. bifidum MIMBb75
With 500 million viable microcultures per capsule
Scientifically tested
Kijimea® is gluten-, fructose-, and lactose-free, as well as free from preservatives, flavorings, and sweeteners.

Recommended Use

Take two Kijimea® capsules once daily with a meal (morning, noon, or evening) without chewing and with sufficient liquid (e.g., a glass of water).

The manufacturer recommends consuming Kijimea® for at least four, preferably twelve weeks.

This product should not be taken if you are allergic to any of the ingredients.

Information on Kijimea Irritable Bowel Syndrome

Important Information

The recommended daily intake should not be exceeded. Food supplements are not a substitute for a balanced, varied diet and a healthy lifestyle.

The manufacturer, Synformulas GmbH, made changes to the product at the beginning of 2024. The proven composition of Kijimea Irritable Bowel Syndrome with the unique bifidobacterial strain B. bifidum MIMBb75 remains the same. However, the product now falls into the category of food supplements and is marketed under the name Kijimea®.

Storage recommendation: Kijimea® should be stored in a dry place below 25°C. Keep out of reach of small children.

Ingredients

Corn starch, microculture mixture (corn starch, B. bifidum MIMBb75), capsule shell: hydroxypropylmethylcellulose; anti-caking agent: magnesium salts of fatty acids, silicon dioxide; colorant: copper complexes of chlorophyllins.

Net weight: 7.28 g (= 28 capsules of 0.26 g each)

Supplier/Manufacturer Address

Synformulas GmbH
Am Haag 14
82166 Gräfelfing